Marco Ledri

Medicine & Life Sciences

1. Optogenetics 100%
2. Interneurons 82%
3. Seizures 64%
4. Epilepsy 63%
5. Neurons 52%
6. Neuropeptide Y 51%
7. Synapses 50%
8. Hippocampus 47%
9. GABAergic Neurons 28%
10. Cannabinoid Receptor CB1 26%
11. Dentate Gyrus 25%
12. Genetic Therapy 25%
13. Parvalbumins 24%
14. Temporal Lobe Epilepsy 23%
15. gamma-Aminobutyric Acid 22%
16. Brain 22%
17. Endocannabinoids 21%
18. Synaptic Transmission 19%
19. Galanin 19%
20. protectin D1 16%
21. Action Potentials 15%
22. Cannabinoids 14%
23. Light 14%
24. Stem Cells 14%
25. Drug Resistant Epilepsy 14%
26. Genes 14%
27. docosapentaenoic acid 14%
28. Clustered Regularly Interspaced Short Palindromic Repeats 13%
29. glyceryl 2-arachidonate 12%
30. Neuronal Plasticity 12%
31. Human Embryonic Stem Cells 12%
32. Neuropeptides 12%
33. Glial Cell Line-Derived Neurotrophic Factor 11%
34. Cholecystokinin 11%
35. Nervous System Diseases 11%
36. Technology 10%
37. Neurodevelopmental Disorders 10%
38. Psychology Transfer 10%
39. Long-Term Potentiation 10%
40. Induced Pluripotent Stem Cells 10%
41. Pyramidal Cells 9%
42. Neuroepithelial Cells 9%
43. Chlorides 9%
44. Stem Cell Transplantation 9%
45. G-Protein-Coupled Receptors 8%
46. Therapeutics 8%
47. In Vitro Techniques 8%
48. Status Epilepticus 8%
49. Galanin Receptors 8%
50. Brain Diseases 8%